Evaluation for Genetic Disorders in the Absence of a Clinical Indication for Testing
- 1 January 2019
- journal article
- research article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 21 (1) , 3-12
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast densityJournal of Medical Screening, 2014
- Assessing the necessity of confirmatory testing for exome-sequencing results in a clinical molecular diagnostic laboratoryGenetics in Medicine, 2014
- Diagnostic Accuracy MeasuresCerebrovascular Diseases, 2013
- ACMG clinical laboratory standards for next-generation sequencingGenetics in Medicine, 2013
- ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencingGenetics in Medicine, 2013
- Next-generation sequencing demands next-generation phenotypingHuman Mutation, 2012
- Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital AnomaliesThe American Journal of Human Genetics, 2010
- Next-Generation Sequencing: A New Revolution in Molecular Diagnostics?Clinical Chemistry, 2009
- An Empiric Estimate of the Value of Life: Updating the Renal Dialysis Cost-Effectiveness StandardValue in Health, 2009
- Revisting wilson and Jungner in the genomic age: a review of screening criteria over the past 40 yearsBulletin of the World Health Organization, 2008